(210) | Number of the EPO application | 17731337 |
(220) | Filing date of the EPO application | 2017.05.24 |
(80) | EPO patent specification publication (B) | EPB nr. 13/2024, 2024.03.27 |
(110) | EPO patent number | 3464306 |
(11) | Number of the document | MD 3464306 T2 |
(21) | Number of the application | e 2019 0424 |
(71) | Name(s) of applicant(s), code of the country | SAREPTA THERAPEUTICS, INC., US; |
(72) | Name(s) of inventor(s), code of the country | CAI Bao, US; MARTINI Mitchell, US; SHIMABUKU Ross, US; THOMAS Katie, US; |
(73) | Name(s) of owner(s), code of the country | SAREPTA THERAPEUTICS, INC., US; |
(54) | Title of the invention | Processes for preparing phosphorodiamidate morpholino oligomers |
(13) | Kind-of-document code | T2 |
(51) | International Patent Classification | C07F 9/6558 (2006.01.01); C07F 9/6561 (2006.01.01); A61P 21/00 (2006.01.01) |
(19) | Country | US |
(41) | Date of publication of the application | 2019.05.31 |
(49) | Date of publication of the translation of the validated European patent specification | 2024.08.31 |
(30) | Priority | 201662340953 P, 2016.05.24, US; 201662357134 P, 2016.06.30, US |
(74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
(86) | International application | PCT/US2017/034284, 2017.05.24 |
(87) | International publication | WO 2017/205513, 2017.11.30 |